Filing Details
- Accession Number:
- 0000899243-19-014292
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-21 20:00:38
- Reporting Period:
- 2019-05-18
- Accepted Time:
- 2019-05-21 20:00:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1351288 | Gw Pharmaceuticals Plc | GWPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1754122 | Volker Knappertz | Sovereign House, Vision Park, Histon Cambridge X0 CB24 9BZ | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2019-05-18 | 12,144 | $0.00 | 97,968 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2019-05-20 | 5,832 | $14.52 | 92,136 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2019-05-20 | 6,312 | $14.76 | 85,824 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Restricted Stock Units | Disposition | 2019-05-18 | 12,144 | $0.00 | 12,144 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-05-18 | 2019-05-18 | No | 4 | M | Direct |
Footnotes
- Vesting of restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018. These ordinary shares are subsequently converted into American Depositary Shares ("ADS") of the Issuer.
- Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.27 U.S. Dollars as of May 17, 2019.
- Includes 49,632 and 27,456 ordinary shares underlying restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018 and Form 4 filed on March 5, 2019, respectively.
- Represented by ADSs.
- The price reported in Column 4 is price per ordinary share converted from price per ADS.
- The price reported in Column 4 is a weighted average price per ordinary share ($177.13 per ADS). These shares were sold in multiple transactions at prices ranging from $177.06 per ADS (or $14.76 per ordinary share) to $177.13 per ADS (or $14.76 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The reporting person's Form 3 filed on October 1, 2018 contained stock options to purchase 12,144 ordinary shares vesting on May 18, 2019 and expiring on March 15, 2020. These securities are restricted stock units with a nominal exercise price and vest automatically upon vesting date.
Billionaire Hedge Funds
